INR comparison between the CoaguChek® Pro PTN and a standard laboratory method

Thrombosis Research

Volumn 113, Issue 5, 2004, Pages 327-332

  Khoschnewis, Schahla ^a   Hannes, Françoise Marie ^b   Tschopp, Markus ^a   Wuillemin, Walter A ^a  

^a LUZERNER KANTONSSPITAL   (Switzerland)

^b Roche Diagnostics AG   (Switzerland)

Author keywords

CoaguChek Pro PTN; Factor deficiency; INR; International Normalized Ratio; International Normalized Ratio (INR); ISI; OAC; Oral anticoagulation; oral anticoagulation; prothrombin time; Prothrombin time; PT; Quick; Thromboplastin time

Indexed keywords

ANTICOAGULANT AGENT; REAGENT; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 10 DEFICIENCY; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BLOOD CLOTTING FACTOR 7 DEFICIENCY; COAGUCHEK; CORRELATION COEFFICIENT; FEMALE; HUMAN; INSTRUMENTATION; INTERMETHOD COMPARISON; LABORATORY TEST; MALE; MEASUREMENT; METHODOLOGY; NORMAL HUMAN; PHOTOMETER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; REGRESSION ANALYSIS;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CAPILLARIES; COAGULATION PROTEIN DISORDERS; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PHENPROCOUMON; PROSPECTIVE STUDIES; PROTHROMBIN TIME; VEINS;

EID: 2942597857     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.03.021     Document Type: Article

References (13)

1. Hirsh J., Dalen J.E., Anderson D.R., Poller L., Bussey H., Ansell J., et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 119(1):2001;8S-21S
2. Niederer A., Wuillemin W.A., de Moerloose P. Orale Antikoagulation: Praktisches Vorgehen. Schweiz. Med. Forum. 17(1):2001;425-430
3. Wuillemin W.A., Burri S., Lämmle B. Quick-Messung aus Kapillar-Blut mittels CoaguChek® oder CoaguChek® Plus. Labolife. 3(1):1997;9-12
4. Kendall J., Reeves B., Clancy M. Point of care testing: randomised controlled trial of clinical outcome. BMJ. 316(1):1998;1052-1057
5. Eisenwiener H.G., Bablok W., Bardorff W., Bender R., Markowetz D., Passing H., et al. Statistische Auswertung beim Methodenvergleich. Lab. Med. 8(1):1984;232-244
6. Anderson D.R., Harrison L., Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch. Intern. Med. 153(1):1993;1441-1447
7. Burri S., Demarmels Biasiutti F., Lämmle B., Wuillemin W.A. Vergleich der Quick-/INR-Werte aus kapillärem Vollblut (CoaguChek® Plus) und venösem Citratplasma bei Patienten mit und ohne orale Antikoagulation. Schweiz. Med. Wochenschr. 128(1):1998;1723-1729
8. Caliezi C., Waber M., Pfiffner D., Saner H., Lämmle B., Wuillemin W.A. Patienten - Selbstkontrolle der oralen Antikoagulation mit CoaguChek® Schweiz. Med. Wochenschr. 130(1):2000;916-924
9. Lämmle B., Furlan M., Sulzer I. Vergleich eines sensitiven Kaninchenhirn - Thromboplastins und eines humanen Plazenta - Thromboplastins zur Thromboplastinzeitbestimmung. Schweiz. Med. Wochenschr. 119(1):1989;178-183
10. van den Besselaar A.M.H.P., Breddin K., Lutze G., Parker-Williams J., Taborski U., Vogel G., et al. Multicenter evaluation of a new capillary blood Prothrombin Time monitoring system. Blood Coagul. Fibrinolysis. 6(1):1995;726-732
11. Keown M., Poller L., Chauhan N., van den Besselaar A.M.H.P., Tripodi A., Shiach C., et al. European concerted action on anticoagulation (ECCA). Reliability of international normalized ratios (INR) from CoaguChek Mini and TAS PT-NC whole blood point-of-care test monitor systems. Br. J. Haematol. 121(Suppl. 1):2003;5-7
12. Poller L., Keown M., Chauhan N., van den Besselaar A.M.H.P., Tripodi A., Shiach C., et al. European concerted action on anticoagulation. Correction of displayed international normalized ratio on two point-of-care test whole-blood prothrombin time monitors (CoaguChek Mini and TAS PT-NC) by independent international sensitivity index calibration. Br. J. Haematol. 122(1):2003;944-949
13. The Le D., Weibert R.T., Sevilla B.K., Donnelly K.J., Rapaport S.I. The International Normalized Ratio (INR) for monitoring warfarin therapy: reliability and relation to other monitoring methods. Ann. Intern. Med. 120(1):1994;552-558